CHAMPIONS ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $3.19 per share for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-07-31 was $3.19, a 26.33% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-01-31 was $3.54, a 34.09% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-10-31 was $0.00, a 100.00% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-07-31 was $4.33, a 43.38% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $4.10, a 43.36% increase from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $2.86, a 23.73% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $3.75, a 12.99% decline from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $4.31, a 22.48% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $3.19 10-Q · filed 2026-09-11 | |||||||
| 2026-04-30 | $4.10 10-K · filed 2026-07-27 | |||||||
| 2026-01-31 | $3.54 10-Q · filed 2026-03-12 | $4.16 10-Q · filed 2026-03-12 | ||||||
| 2025-10-31 | $0.00 10-Q · filed 2025-12-15 | $4.33 10-Q · filed 2025-12-15 | ||||||
| 2025-07-31 | $4.33 10-Q · filed 2026-09-11 | |||||||
| 2025-04-30 | $2.86 10-K · filed 2026-07-27 | |||||||
| 2025-01-31 | $2.64 10-Q · filed 2026-03-12 | $2.58 10-Q · filed 2026-03-12 | ||||||
| 2024-10-31 | $2.48 10-Q · filed 2025-12-15 | $2.49 10-Q · filed 2025-12-15 | ||||||
| 2024-07-31 | $3.02 10-Q · filed 2025-09-15 | |||||||
| 2024-04-30 | $3.75 10-K · filed 2025-07-23 | |||||||
| 2024-01-31 | $3.41 10-Q · filed 2025-03-17 | $3.77 10-Q · filed 2025-03-17 | ||||||
| 2023-10-31 | $4.02 10-Q · filed 2024-12-16 | $3.95 10-Q · filed 2024-12-16 | ||||||
| 2023-07-31 | $3.72 10-Q · filed 2024-09-13 | |||||||
| 2023-04-30 | $4.31 10-K · filed 2024-07-19 | |||||||
| 2023-01-31 | $4.20 10-Q · filed 2024-03-15 | $4.33 10-Q · filed 2024-03-15 | ||||||
| 2022-10-31 | $0.00 10-Q · filed 2023-12-13 | $4.50 10-Q · filed 2023-12-13 | ||||||
| 2022-07-31 | $4.50 10-Q · filed 2023-09-13 | |||||||
| 2022-04-30 | $5.56 10-K · filed 2023-07-24 | |||||||
| 2022-01-31 | $5.80 10-Q · filed 2023-03-16 | $5.56 10-Q · filed 2023-03-16 | ||||||
| 2021-10-31 | $5.33 10-Q · filed 2022-12-13 | |||||||
| 2021-07-31 | $5.33 10-Q · filed 2022-09-12 | |||||||
| 2021-04-30 | $5.11 10-K · filed 2022-07-22 | |||||||
| 2021-01-31 | $5.80 10-Q · filed 2022-03-15 | $5.08 10-Q · filed 2022-03-15 | ||||||
| 2020-10-31 | $7.05 10-Q · filed 2021-12-13 | $7.29 10-Q · filed 2021-12-13 | ||||||
| 2020-07-31 | $9.85 10-Q · filed 2021-09-13 | |||||||
| 2020-04-30 | $5.33 10-K · filed 2021-07-26 | |||||||
| 2020-01-31 | $2.56 10-Q · filed 2021-03-15 | $3.09 10-Q · filed 2021-03-15 | ||||||
| 2019-10-31 | $3.32 10-Q · filed 2020-12-14 | $3.32 10-Q · filed 2020-12-14 | ||||||
| 2019-07-31 | $5.18 10-Q · filed 2019-09-16 | |||||||
| 2019-04-30 | $6.03 10-K · filed 2020-07-28 | |||||||
| 2019-01-31 | $5.76 10-Q · filed 2020-03-16 | $6.03 10-Q · filed 2020-03-16 | ||||||
| 2018-10-31 | $6.17 10-Q · filed 2019-12-16 | $6.16 10-Q · filed 2019-12-16 | ||||||
| 2018-07-31 | $5.18 10-Q · filed 2018-09-14 | |||||||
| 2018-04-30 | $2.19 10-K · filed 2019-07-29 | |||||||
| 2018-01-31 | $2.32 10-Q · filed 2019-03-18 | $1.95 10-Q · filed 2019-03-18 | ||||||
| 2017-10-31 | $0.00 10-Q · filed 2018-12-17 | $1.84 10-Q · filed 2018-12-17 | ||||||
| 2017-07-31 | $1.79 10-Q · filed 2018-09-14 | $1.84 10-Q · filed 2017-09-14 | ||||||
| 2017-04-30 | $1.71 10-K · filed 2018-07-30 | |||||||
| 2017-01-31 | $1.35 10-Q · filed 2018-03-19 | $1.71 10-Q · filed 2018-03-19 | ||||||
| 2016-10-31 | $1.16 10-Q · filed 2017-12-15 | $1.73 10-Q · filed 2017-12-15 | ||||||
| 2016-07-31 | $1.79 10-Q · filed 2017-09-14 | |||||||
| 2016-04-30 | $3.54 10-K · filed 2017-07-28 | |||||||
| 2016-01-31 | $3.12 10-Q · filed 2017-03-17 | $3.60 10-Q · filed 2017-03-17 | ||||||
| 2015-10-31 | $5.47 10-Q · filed 2016-12-14 | $4.99 10-Q · filed 2016-12-14 | ||||||
| 2015-07-31 | $4.85 10-Q · filed 2016-09-14 | |||||||
| 2015-04-30 | $7.32 10-K · filed 2016-07-29 | $0.61 10-K · filed 2015-07-29 | ||||||
| 2015-01-31 | $0.00 10-Q · filed 2015-03-17 | $8.04 10-Q · filed 2016-03-16 | $0.67 10-Q · filed 2015-03-17 | |||||
| 2014-10-31 | $8.28 10-Q · filed 2015-12-15 | $0.69 10-Q · filed 2014-12-15 | $11.28 10-Q · filed 2015-12-15 | $0.71 10-Q · filed 2014-12-15 | ||||
| 2014-07-31 | $8.28 10-Q · filed 2015-09-11 | $0.69 10-Q · filed 2014-09-12 | ||||||
| 2014-04-30 | $0.96 10-K · filed 2015-07-29 | |||||||
| 2014-01-31 | $0.97 10-Q · filed 2015-03-17 | $0.96 10-Q · filed 2015-03-17 | ||||||
| 2013-10-31 | $1.06 10-Q · filed 2014-12-15 | $0.94 10-Q · filed 2014-12-15 | ||||||
| 2013-07-31 | $0.40 10-Q · filed 2014-09-12 | |||||||
| 2013-04-30 | $0.41 10-K · filed 2014-07-28 | |||||||
| 2013-01-31 | $0.27 10-Q · filed 2014-03-14 | $0.36 10-Q · filed 2014-03-14 | ||||||
| 2012-10-31 | $0.26 10-Q · filed 2013-12-13 | $0.52 10-Q · filed 2013-12-13 | ||||||
| 2012-07-31 | $0.54 10-Q · filed 2013-09-13 | |||||||
| 2012-04-30 | $0.58 10-K · filed 2013-07-26 | |||||||
| 2012-01-31 | $0.52 10-Q · filed 2013-03-13 | $0.57 10-Q · filed 2013-03-13 | ||||||
| 2011-10-31 | $0.37 10-Q · filed 2012-12-13 | $0.63 10-Q · filed 2012-12-13 | ||||||
| 2011-07-31 | $0.74 10-Q · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |